These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 15958724

  • 21. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
    Wu Y, Chen Y, Qu R, Lan T, Sang J.
    Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
    [Abstract] [Full Text] [Related]

  • 22. cAMP-responsive element binding protein mediates a cGMP/protein kinase G-dependent anti-apoptotic signal induced by nitric oxide in retinal neuro-glial progenitor cells.
    Nagai-Kusuhara A, Nakamura M, Mukuno H, Kanamori A, Negi A, Seigel GM.
    Exp Eye Res; 2007 Jan; 84(1):152-62. PubMed ID: 17081519
    [Abstract] [Full Text] [Related]

  • 23. Nitric oxide modulates stretch activation of mitogen-activated protein kinases in mesangial cells.
    Ingram AJ, James L, Ly H, Thai K, Cai L, Scholey JW.
    Kidney Int; 2000 Sep; 58(3):1067-77. PubMed ID: 10972671
    [Abstract] [Full Text] [Related]

  • 24. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells.
    Oliveira CJ, Schindler F, Ventura AM, Morais MS, Arai RJ, Debbas V, Stern A, Monteiro HP.
    Free Radic Biol Med; 2003 Aug 15; 35(4):381-96. PubMed ID: 12899940
    [Abstract] [Full Text] [Related]

  • 25. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
    Rodriguez-Pascual F, Miras-Portugal MT, Torres M.
    Mol Pharmacol; 1996 Jun 15; 49(6):1058-70. PubMed ID: 8649344
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, Molkentin JD, Drexler H, Wollert KC.
    Proc Natl Acad Sci U S A; 2002 Aug 20; 99(17):11363-8. PubMed ID: 12177418
    [Abstract] [Full Text] [Related]

  • 27. Exogenous nitric oxide upregulates p21(waf1/cip1) in pulmonary microvascular smooth muscle cells.
    Stotz WH, Li D, Johns RA.
    J Vasc Res; 2004 Aug 20; 41(3):211-9. PubMed ID: 15051933
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
    Wu BN, Chen CW, Liou SF, Yeh JL, Chung HH, Chen IJ.
    Mol Pharmacol; 2006 Sep 20; 70(3):977-85. PubMed ID: 16754782
    [Abstract] [Full Text] [Related]

  • 29. Glutamate modulates sodium-potassium-ATPase through cyclic GMP and cyclic GMP-dependent protein kinase in rat striatum.
    Munhoz CD, Kawamoto EM, de Sá Lima L, Lepsch LB, Glezer I, Marcourakis T, Scavone C.
    Cell Biochem Funct; 2005 Sep 20; 23(2):115-23. PubMed ID: 15624118
    [Abstract] [Full Text] [Related]

  • 30. Protein kinase G may exert pro-degradation inhibition on nitric oxide synthase.
    John TA.
    Niger J Physiol Sci; 2011 Nov 28; 26(1):1-6. PubMed ID: 22314978
    [Abstract] [Full Text] [Related]

  • 31. Nitric-oxide-dependent activation of pig oocytes: the role of the cGMP-signalling pathway.
    Petr J, Rajmon R, Chmelíková E, Tománek M, Lánská V, Pribánová M, Jílek F.
    Zygote; 2006 Feb 28; 14(1):9-16. PubMed ID: 16700970
    [Abstract] [Full Text] [Related]

  • 32. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.
    Doronzo G, Viretto M, Russo I, Mattiello L, Di Martino L, Cavalot F, Anfossi G, Trovati M.
    Atherosclerosis; 2011 May 28; 216(1):44-53. PubMed ID: 21316056
    [Abstract] [Full Text] [Related]

  • 33. Sodium nitroprusside activates p38 mitogen activated protein kinase through a cGMP/PKG independent mechanism.
    Rabkin SW, Klassen SS, Tsang MY.
    Life Sci; 2007 Aug 02; 81(8):640-6. PubMed ID: 17707440
    [Abstract] [Full Text] [Related]

  • 34. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide.
    Bauer PM, Buga GM, Ignarro LJ.
    Proc Natl Acad Sci U S A; 2001 Oct 23; 98(22):12802-7. PubMed ID: 11592976
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
    Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E, Trautwein C, Lohmann SM, Drexler H.
    Hypertension; 2002 Jan 23; 39(1):87-92. PubMed ID: 11799084
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Nitric oxide regulates prolidase activity by serine/threonine phosphorylation.
    Surazynski A, Liu Y, Miltyk W, Phang JM.
    J Cell Biochem; 2005 Dec 01; 96(5):1086-94. PubMed ID: 16167338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.